Kelly del Carmen Cruz-Salomón has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antinociceptive Activity of Petiveria alliacea L. Extract via GABAergic and Serotonergic Pathways in Diabetic Neuropathy Model

    by Kelly del C. Cruz-Salomón, Alfredo Briones-Aranda, Abumalé Cruz-Salomón, Nancy Ruiz-Lau, Mariano Martínez-Vázquez, Joaquín A. Montes-Molina, Gerardo Leyva-Padrón, Josue V. Espinosa-Juárez, Rosa I. Cruz-Rodríguez

    Petiveria alliacea L. (commonly known as “anamu,” “guiné,” “hierba de zorro,” and “tipi”) has been widely used in Mesoamerican traditional medicine to treat pain and inflammation. However, scientific evidence supporting its efficacy in diabetic neuropathy remains limited. This study evaluated the antinociceptive potential of a methanolic leaf extract of P. alliacea in a murine model of alloxan-induced diabetic neuropathy and investigated its possible mechanisms of action. Diabetic CD-1 mice were evaluated for mechanical allodynia and hyperalgesia using the Von Frey test and for tonic pain using the formalin test. Pharmacological antagonists were administered to assess the involvement of opioid, nitric oxide, serotonergic, and GABAergic pathways. Phytochemical profiling was performed by LC-ESI-MS/MS, and potential pharmacological and pharmacokinetic properties of the identified metabolites were predicted using in silico tools (PASS online, SwissTargetPrediction, SwissADME, and pkCSM). The methanolic extract significantly reduced mechanical allodynia and hyperalgesia in diabetic mice and attenuated nociceptive responses in both phases of the formalin test, showing an effect comparable to gabapentin. Antinociceptive activity was not altered by naloxone or L-NAME but was significantly attenuated by methiothepin and bicuculline, suggesting that serotonergic and GABAergic pathways contribute, at least in part, to the observed antinociceptive effects. LC-ESI-MS/MS analysis identified 38 metabolites, including flavonoids, alkaloids, and terpenes, with in silico predictions supporting their potential analgesic and anti-inflammatory activities. The methanolic leaf extract of P. alliacea exhibits significant antinociceptive activity in diabetic neuropathy, partially likely to involve serotonergic and GABAergic mechanisms, supporting its ethnomedicinal use and its potential as a source of novel analgesic agents.

  • Open Access

    Antibacterial Activity of Traditional Medicinal Plants Used for the Treatment of Acute Diarrheal Diseases in Chiapas, Mexico

    by Jesús Mauricio Ernesto Hernández-Méndez, Israel Peña-Hernández, Mariela Tapia-Nazario, Gerardo Leyva-Padrón, Abumalé Cruz-Salomón, María Emperatriz Domínguez-Espinosa, Héctor Armando Esquinca-Avilés, Maritza del Carmen Hernández-Cruz, Rocío Magdalena Sánchez-Albores, Kelly del Carmen Cruz-Salomón, et al.

    The Enterobacteriaceae family poses health risks due to its role in gastrointestinal diseases like acute diarrhea. With rising antibiotic resistance, plants offer promising antibacterial compounds with low toxicity. This study evaluated the antibacterial activity, minimum inhibitory concentration (MIC), and toxicity of ethanolic (EE) and aqueous (AE) extracts from five Mexican medicinal plants traditionally used in Chiapas for treating acute diarrheal diseases (ADD). Antibacterial activity was assessed using disk diffusion assays and MIC determined by macrodilution. Toxicity tests were performed using Artemia salina. As a result, EE extracts exhibited higher antibacterial activity than AE extracts. Byrsonima crassifolia effectively inhibited Salmonella enteritidis (78.26%, MIC 50 mg/mL) and Shigella dysenteriae (76.19%, MIC 25 mg/mL). Solanum torvum showed efficacy against Escherichia coli (55.55%, MIC 12.5 mg/mL) and Salmonella enteritidis (73.91%, MIC 25 mg/mL). Euphorbia maculata inhibited Shigella dysenteriae (104.76%, MIC 25 mg/mL), while Guazuma ulmifolia and Bursera simaruba exhibited no antibacterial effects. All extracts were non-toxic (LD50 > 1000 μg/mL), indicating potential as natural alternatives for ADD treatment.


  • Open Access

    Sustainable Ice Cream Base: Harnessing Mango Seed Kernel (Mangifera indica L. var. Tommy Atkins) Waste and Cheese Whey

    by Pedro Gerardo Trejo-Flores, Lester Alejandro Santiago-Rodríguez, María Emperatriz Domínguez-Espinosa, Abumalé Cruz-Salomón, Paulina Elizabeth Velázquez-Jiménez, Jesús Mauricio Ernesto Hernández-Méndez, Mario Alberto Morales-Ovando, Kelly del Carmen Cruz-Salomón, Maritza del Carmen Hernández-Cruz, Paola Tayde Vázquez-Villegas, et al.

    The agro-food industry plays a crucial role in enhancing living standards; however, inadequate losses and waste management persists as significant challenges within its processes. Particularly, mango and cheese processing generate substantial waste, leading to ecological disruptions, economic losses, and concerns related to food security and public health. To address these issues, this study was aimed at utilizing this waste to produce a high-quality ice cream base, thereby valorizing the discarded materials. This approach not only adds nutritional value but also contributes to food security and sovereignty. The raw materials (cheese whey, oil, and starch) were subjected to physicochemical characterization, leading to the development of three different ice cream base formulations. Subsequently, the ice cream bases were evaluated for their physicochemical, functional, and sensory properties. The findings of this study revealed that mango seed kernel and cheese whey waste contain valuable components that enable the creation of an ice cream base with excellent physicochemical, functional, and sensory properties. Moreover, this research showcases a promising solution for effectively valorizing food waste and generating value-added products such as ice cream, thus promoting sustainability and resource optimization within the agro-food industry.


  • Open Access

    In Vivo and In Silico Study of the Antinociceptive and Toxicological Effect of the Extracts of Petiveria alliacea L. Leaves

    by Kelly del Carmen Cruz-Salomón, Rosa Isela Cruz-Rodríguez, Josué Vidal Espinosa-Juárez, Abumalé Cruz-Salomón, Alfredo Briones-Aranda, Nancy Ruiz-Lau, Víctor Manuel Ruíz-Valdiviezo

    Petiveria alliacea L. is an herb used in traditional medicine in Mexico and its roots have been studied to treat pain. However, until now, the antinociceptive properties of the leaves have not been investigated, being the main section used empirically for the treatment of diseases. For this reason, this study aimed to evaluate the antinociceptive and toxoicological activity of various extracts (aqueous, hexanic, and methanolic) from P. alliacea L. leaves in NIH mice and to perform an in silico analysis of the phytochemical compounds. Firstly, the antinociceptive effect was analyzed using the formalin model and the different doses of each of the extracts that were administered orally to obtain the dose–response curves. In addition, acute toxicity was determined by the up and down method and serum biochemical analysis. Later, the phytochemical study of extracts was carried out by thin layer chromatography (TLC) and visible light spectroscopy, and the volatile chemical components were analyzed by gas chromatography-mass spectrometry (GC/MS). Moreover, the most abundant compounds identified in the phytochemical study were analyzed in silico to predict their biological activity (PASSonline) and toxicology (OSIRIS Property Explorer). As a result, it was known that all extracts at doses from 10 to 316 mg/kg significantly reduced the pain response in both phases of the formalin model, with values of 50–60% for the inflammatory response. The toxicological studies (DL50) exhibited that all extracts did not cause any mortality up to the 2000 mg/kg dose level. This was corroborated by the values in the normal range of the biochemical parameters in the serum. Finally, the phytochemical screening of the presence of phenolic structures (coumarins, flavonoids) and terpenes (saponins and terpenes) was verified, and the highest content was of a lipid nature, 1.65 ± 0.54 meq diosgenin/mL in the methanolic extract. A total of 54 components were identified, 11 were the most abundant, and only four (Eicosane, Methyl oleate, 4-bis(1-phenylethyl) phenol, and Ethyl linolenate) of them showed a probability towards active antinociceptive activity in silico greater than 0.5. These results showed that the P. alliacea L. leaf extract possesses molecules with antinociceptive activity.


  • Open Access

    Treatment of Cheese Whey Wastewater Using an Expanded Granular Sludge Bed (EGSB) Bioreactor with Biomethane Production

    by Abumalé Cruz-Salomón, Edna Ríos-Valdovinos, Francisco Pola-Albores, Selene Lagunas-Rivera, Rosa Isela Cruz-Rodríguez, Kelly del Carmen Cruz-Salomón, Jesús Mauricio Ernesto Hernández-Méndez, María Emperatriz Domínguez-Espinosa

    Cheese whey wastewater (CWW) is the major by-product of the dairy industry. CWW is produced in large quantities, has varied characteristics and is usually disposed of. The disposal of CWW causes a negative impact on the environment of different agroindustrial areas due to the physic-chemical composition that significantly increases its high organic load and nutrients. For this reason, the aim of this work was to carry out an evaluation of the anaerobic treatability of an Expanded Granular Sludge Bed (EGSB) bioreactor as a new sustainable alternative for treatment of these effluents with bioenergy production. In this study, the bioreactor was operated under stable conditions (i.e., buffer index of 0.23 ± 0.1, pH 7.22 ± 0.4 and temperature 26.6 ± 1.4 °C) for 201 days. During evaluation the hydraulic retention time (HRT) was 6 and 8 days, and it was buffered with NaHCO3. At these conditions, the COD removal rate and biochemical methane potential (BMP) were 90, 92%; and 334, 328 mLCH4/gCOD, respectively. The evidence found in this study highlighted that the CWW is a viable substrate to be treated in the EGSB bioreactor as long as it keeps buffered. Furthermore, the process to treat the CWW in an EGSB bioreactor can be a sustainable alternative to simultaneously solve the environmental pollution that this agro-industry confronts and produce renewable and environmentally-friendly bioenergy.